Evaluation of assay kit for detecting SARS-CoV-2 infection

Evaluation of rapid diagnostic test for SARS-CoV-2 infection - Evaluation of rapid diagnostic test for SARS-CoV-2 infection

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044225

Enrollment

200

Registered

2021-06-30

Start date

2021-01-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus disease 2019

Interventions

Sample collection, assay with test kit

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients that visit the medical institution during this study, and include the following conditions: 1) Patients with suspected SARS-CoV-2 infection based on symptoms. 2) Patients who agree to participate in this study.

Exclusion criteria

Exclusion criteria: 1) Patients who are difficult to obtain clinical samples from. 2) For any reason other than above, patients who were determined by doctor as being unfit to participate in this study.

Design outcomes

Primary

Measure	Time frame
Sensitivity, specificity and detection limit of rapid diagnostic test for SARS-CoV-2 infection	—

Countries

Japan

Contacts

Public ContactYuta Maehara

Sekisui Medical Co., Ltd. Research & Development

yuta.maehara@sekisui.com03-3272-0677

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026